K R Ehresmann1, W A Mills, P R Loewenson, K A Moore. 1. Acute Disease Epidemiology Section, Minnesota Department of Health, Minneapolis 55414, USA. kristen.ehresmann@health.state.mn.us
Abstract
OBJECTIVES: This study sought to determine physicians' attitudes and practices regarding varicella vaccine. METHODS: A sample of Minnesota family physicians and pediatricians was surveyed in January 1997. RESULTS: Of 255 physicians surveyed, 108 (42%) reported routinely offering varicella vaccine. Physicians who perceived their professional organization's recommendations as "very important" were more likely to routinely offer varicella vaccine. Physicians who preferred natural disease over vaccination and those concerned about waning immunity were less likely to routinely offer vaccine. CONCLUSIONS: Recommendations of professional organizations have encouraged varicella vaccine use and may further enhance future use. Differences in pediatricians' and family physicians' attitudes and practices regarding this vaccine suggest that education of providers by specialty may be needed to increase acceptance of newly licensed vaccines.
OBJECTIVES: This study sought to determine physicians' attitudes and practices regarding varicella vaccine. METHODS: A sample of Minnesota family physicians and pediatricians was surveyed in January 1997. RESULTS: Of 255 physicians surveyed, 108 (42%) reported routinely offering varicella vaccine. Physicians who perceived their professional organization's recommendations as "very important" were more likely to routinely offer varicella vaccine. Physicians who preferred natural disease over vaccination and those concerned about waning immunity were less likely to routinely offer vaccine. CONCLUSIONS: Recommendations of professional organizations have encouraged varicella vaccine use and may further enhance future use. Differences in pediatricians' and family physicians' attitudes and practices regarding this vaccine suggest that education of providers by specialty may be needed to increase acceptance of newly licensed vaccines.
Authors: S Black; H Shinefield; P Ray; E Lewis; J Hansen; J Schwalbe; P Coplan; R Sharrar; H Guess Journal: Pediatr Infect Dis J Date: 1999-12 Impact factor: 2.129
Authors: T A Lieu; S L Cochi; S B Black; M E Halloran; H R Shinefield; S J Holmes; M Wharton; A E Washington Journal: JAMA Date: 1994-02-02 Impact factor: 56.272
Authors: Daniel A Salmon; William K Y Pan; Saad B Omer; Ann Marie Navar; Walter Orenstein; Edgar K Marcuse; James Taylor; M Patricia deHart; Shannon Stokley; Terrell Carter; Neal A Halsey Journal: Hum Vaccin Date: 2008-02-19
Authors: Barbara P Yawn; Clayton Schroeder; Peter Wollan; Liliana Rocca; Rick Zimmerman; Barbara Bardenheier Journal: BMC Fam Pract Date: 2006-08-15 Impact factor: 2.497
Authors: Raúl Herzog; María José Álvarez-Pasquin; Camino Díaz; José Luis Del Barrio; José Manuel Estrada; Ángel Gil Journal: BMC Public Health Date: 2013-02-19 Impact factor: 3.295
Authors: Michelle J Mergler; Saad B Omer; William K Y Pan; Ann Marie Navar-Boggan; Walter Orenstein; Edgar K Marcuse; James Taylor; M Patricia deHart; Terrell C Carter; Anthony Damico; Neal Halsey; Daniel A Salmon Journal: Vaccines (Basel) Date: 2013-04-29